project id: TCGA-LUAD; case submitter id: TCGA-86-8074; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; state: released; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.32; age at index: 62; days to birth: -22862; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1949; age at diagnosis: 22862; ajcc pathologic m: M0; ajcc pathologic n: N1; ajcc pathologic stage: Stage IIA; ajcc pathologic t: T1b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 24.0; icd 10 code: C34.3; last known disease status: not reported; morphology: 8260/3; primary diagnosis: Papillary adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Lower lobe, lung; synchronous malignancy: No; tissue or organ of origin: Lower lobe, lung; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: not reported; alcohol history: Not Reported; cigarettes per day: 2.191780821917808; pack years smoked: 40.0; is ffpe: false; composition: Not Reported; days to sample procurement: 0; intermediate dimension: 1.3; longest dimension: 2.3; oct embedded: No; shortest dimension: 0.3; portion submitter id: TCGA-86-8074-01A-11; percent lymphocyte infiltration: 8.0; percent necrosis: 2.0; percent normal cells: 2.0; percent stromal cells: 0.0; percent tumor cells: 96.0; percent tumor nuclei: 80.0;